Common Contracts
1 similar Exclusive Agreement contracts
CLOVER ENTERS INTO EXCLUSIVE AGREEMENT TO COMMERCIALIZE QUADRIVALENT SEASONALExclusive Agreement • April 21st, 2021
This announcement is made by the board (the “Board”) of directors (the “Directors”) of Clover Biopharmaceuticals, Ltd. (the “Company” or “Clover”, together with its subsidiaries, the “Group”) pursuant to Rule 13.09(2)(a) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the “Listing Rules”) and the Inside Information Provisions (as defined in the Listing Rules) under Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong).
